Your browser doesn't support javascript.
loading
Geranylgeranyl transferase 1 inhibitor GGTI­298 enhances the anticancer effect of gefitinib.
Liu, Bi-Sheng; Dai, Xin-Yu; Xia, Hong-Wei; Xu, Huan-Ji; Tang, Qiu-Lin; Gong, Qi-Yong; Nie, Yong-Zhan; Bi, Feng.
Afiliação
  • Liu BS; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Dai XY; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Xia HW; Laboratory of Molecular Targeted Therapy in Oncology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Xu HJ; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Tang QL; Laboratory of Molecular Targeted Therapy in Oncology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Gong QY; Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Nie YZ; State Key Laboratory of Cancer Biology and Xijing Hospital of Digest Diseases, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
  • Bi F; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Mol Med Rep ; 18(4): 4023-4029, 2018 Oct.
Article em En | MEDLINE | ID: mdl-30106149

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzamidas / Alquil e Aril Transferases / Inibidores Enzimáticos / Gefitinibe / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Med Rep Ano de publicação: 2018 Tipo de documento: Article País de publicação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzamidas / Alquil e Aril Transferases / Inibidores Enzimáticos / Gefitinibe / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Med Rep Ano de publicação: 2018 Tipo de documento: Article País de publicação: Grécia